S. Robinson

D. Wood, S. Mehta, J. Webb, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Endothelial Fibrinolytic Capacity Predicts Future Adverse Cardiovascular Events in Patients With Coronary Heart Disease

D. Newby, S. Robinson, N. Boon, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Double-Blind, Placebo-Controlled Evaluation of Biorest Liposomal Alendronate in Diabetic Patients Undergoing PCI: The BLADE-PCI Trial: The BLADE-PCI Trial.

G. Stone, R. de Silva, A. Assali, 2022, American heart journal.

Tissue plasminogen activator genetic polymorphisms do not influence tissue plasminogen activator release in patients with coronary heart disease

D. Newby, S. Robinson, N. Boon, 2006, Journal of thrombosis and haemostasis : JTH.

Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease

D. Newby, S. Robinson, N. Boon, 2005, Heart.

Successful transcatheter aortic valve replacement in a patient with a sinus of Valsalva aneurysm.

S. Robinson, I. Nadra, C. Hendry, 2014, JACC. Cardiovascular interventions.

Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.

D. Newby, S. Robinson, N. Boon, 2006, Clinical science.

Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease

D. Newby, K. Fox, S. Robinson, 2006, Platelets.

LETTERS TO THE EDITOR: Inhibition of thrombin activatable fibrinolysis inhibitor augments fibrinolysis in human whole blood

D. Newby, S. Robinson, N. Cruden, 2005, Journal of thrombosis and haemostasis : JTH.

Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease.

S. Robinson, E. Aymong, A. Fung, 2017, JACC. Cardiovascular interventions.

Synthesis and Cardiac Imaging of (18)F-Ligands Selective for β1-Adrenoreceptors.

P. Yalamanchili, S. Robinson, T. Harris, 2011, ACS medicinal chemistry letters.

Reply: The Effect of Survivor Bias on Observational Analyses of Staged PCI in STEMI Patients.

S. Robinson, I. Nadra, L. Ding, 2017, JACC. Cardiovascular interventions.

Intra-Aortic Balloon Pump Counterpulsation during Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry

S. Robinson, E. Aymong, A. Fung, 2016, PLoS ONE.

Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk

W. MacNee, D. Newby, I. Wilkinson, 2007, Thorax.

Radial artery pseudoaneurysms after transradial cardiac catheterisation.

S. Robinson, A. Murphy, J. Din, 2016, VASA. Zeitschrift fur Gefasskrankheiten.

Delay in Filling First Clopidogrel Prescription After Coronary Stenting Is Associated With an Increased Risk of Death and Myocardial Infarction

S. Robinson, R. Carere, N. Cruden, 2014, Journal of the American Heart Association.

Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents.

P. Yalamanchili, S. Robinson, Shuang Liu, 2006, Bioconjugate chemistry.

Cardiac imaging and uptake mechanism of 18F LMI1195, a novel PET cardiac neuronal imaging agent

P. Yalamanchili, S. Robinson, M. Azure, 2010 .

Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.

P. Yalamanchili, S. Robinson, T. Harris, 2003, Cancer biotherapy & radiopharmaceuticals.

Radiation dose to abdominal organs of the mouse due to 90Y in the urinary bladder.

S. Robinson, J. Lazewatsky, D. Onthank, 2003, Cancer biotherapy & radiopharmaceuticals.

Role of inflammation in cardiopulmonary health effects of PM.

W. MacNee, D. Newby, S. Robinson, 2005, Toxicology and applied pharmacology.

Environmental, genetic and inflammatory factors modifying endothelial function in patients with coronary heart disease

S. Robinson, 2007 .

Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study

D. Newby, S. Robinson, N. Mills, 2013, Heart.

Air Pollution and Atherothrombosis

T. Sandström, D. Newby, S. Söderberg, 2007, Inhalation toxicology.

Increased arterial stiffness in patients with chronic obstructive pulmonary disease; a mechanism for increased cardiovascular risk COPD and arterial stiffness

David G. Anderson, W. MacNee, D. Newby, 2007 .

Embolic protection device use and its association with procedural safety and long‐term outcomes following saphenous vein graft intervention: An analysis from the British Columbia Cardiac registry

S. Robinson, E. Aymong, A. Fung, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Do inhaled carbon nanoparticles translocate directly into the circulation in humans?

David E Newby, Flemming R Cassee, Jesus M de la Fuente, 2006, American journal of respiratory and critical care medicine.

Quality-of-Life Outcomes After Transcatheter Aortic Valve Implantation in a “Real World” Population: Insights From a Prospective Canadian Database

D. Wood, S. Lauck, J. Webb, 2021, CJC open.

Exposure to Concentrated Ambient Particles Does Not Affect Vascular Function in Patients with Coronary Heart Disease

David G. Anderson, T. Sandström, M. Heal, 2008, Environmental health perspectives.

Long‐term outcomes following drug‐eluting stents versus bare metal stents for primary percutaneous coronary intervention: A real‐world analysis of 11,181 patients from the british columbia cardiac registry

S. Robinson, E. Aymong, A. Fung, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Provision of gastroprotective medication and bleeding risk following acute coronary syndrome.

B. Keavney, A. Yan, A. Zaman, 2013, The Journal of invasive cardiology.

Complete revascularization in stable multivessel coronary artery disease: A real world analysis from the British Columbia Cardiac Registry

D. Wood, S. Mehta, J. Webb, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prognostic Significance of Polymer Coatings in Zotarolimus-Eluting Stents.

S. Robinson, E. Aymong, A. Fung, 2016, The American journal of cardiology.

Implications of Transcatheter Heart Valve Selection on Early and Late Pacemaker Rate and on Length of Stay.

S. Lauck, A. Cheung, J. Polderman, 2018, The Canadian journal of cardiology.

Dosimetry of BMS747158, a novel 18F labeled tracer for myocardial perfusion imaging, in nonhuman primates at rest

S. Robinson, J. Lazewatsky, M. Azure, 2008 .

Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF+PCI-II Program.

A. Bagai, W. Cantor, A. Yan, 2021, Journal of cardiology.

Response to the letter regarding the article “Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention”

S. Robinson, C. Janssen, W. Klinke, 2010 .

Huge aortic pseudoaneurysm arising from the coronary anastomosis after aortic root replacement.

S. Robinson, J. Din, D. Wong, 2013, QJM : monthly journal of the Association of Physicians.

Do inhaled carbon nanoparticles translocate directly into the circulation in humans?

D. Newby, F. Cassee, S. Robinson, 2006, American journal of respiratory and critical care medicine.

Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents in Patients with Coronary Artery Disease: Primary Results from the BIONICS Trial

E. Edelman, G. Stone, A. Íñiguez, 2017 .